Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.
Our top-notch dedicated system is used to design specialised libraries.
Fig. 1. The sreening workflow of Receptor.AI
Utilising molecular simulations, our approach thoroughly examines a wide array of proteins, tracking their conformational changes individually and within complexes. Ensemble virtual screening enables us to address conformational flexibility, revealing essential binding sites at functional regions and allosteric locations. Our rigorous analysis guarantees that no potential mechanism of action is overlooked, aiming to uncover new therapeutic targets and lead compounds across diverse biological functions.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
Q8NI77
UPID:
KI18A_HUMAN
Alternative names:
Marrow stromal KIF18A
Alternative UPACC:
Q8NI77; Q4VPE3; Q86VS5; Q9H0F3
Background:
Kinesin-like protein KIF18A, also known as Marrow stromal KIF18A, is a microtubule-depolymerizing kinesin. It plays a crucial role in chromosome congression by moderating preanaphase oscillations and decelerating poleward movement during anaphase, effectively suppressing excessive chromosome movements. KIF18A is instrumental in stabilizing the CENPE-BUB1B complex at kinetochores in early mitosis and maintaining CENPE levels at kinetochores during chromosome congression.
Therapeutic significance:
Understanding the role of Kinesin-like protein KIF18A could open doors to potential therapeutic strategies.